cefbuperazone has been researched along with fortimicin a sulfate in 1 studies
| Studies (cefbuperazone) | Trials (cefbuperazone) | Recent Studies (post-2010) (cefbuperazone) | Studies (fortimicin a sulfate) | Trials (fortimicin a sulfate) | Recent Studies (post-2010) (fortimicin a sulfate) |
|---|---|---|---|---|---|
| 92 | 5 | 1 | 64 | 2 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haranaka, K; Haranaka, R; Iimura, F; Sakurai, A; Satomi, N | 1 |
1 other study(ies) available for cefbuperazone and fortimicin a sulfate
| Article | Year |
|---|---|
Preventive effect of several drugs against Pseudomonas aeruginosa infection and the toxicity of combined tumor necrosis factor with lipopolysaccharide: relationship between lethality and the arachidonic cascade.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Antibodies; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arachidonic Acid; Arachidonic Acids; Cephamycins; Chromones; Drug Synergism; Drugs, Chinese Herbal; Female; Leukotriene Antagonists; Leukotriene E4; Lipopolysaccharides; Mice; Mice, Inbred Strains; Platelet Activating Factor; Polymyxin B; Pseudomonas Infections; Recombinant Proteins; SRS-A; Tumor Necrosis Factor-alpha | 1990 |